ÂÜÀòÂÒÂ×

Hamed Reyhanfard, Pharm.D, EMBA has over seven years of experience in the pharmaceutical industry. In 2014, they began their career as a Business Development Consultant at ONSET CAPITAL PARTNERS. In 2015, they joined Janssen Europe, Middle East & Africa (EMEA) as a Pharmaceutical BD. In 2017, they became the BD, Oncology & Immunology Business Unit at Janssen, EMEA. In 2019, they joined Chimeron Bio as an Associate Director, Business Development. In 2021, they became the Director Of Investment Development at Infusion 51a LP, a modern impact investment fund focused on Health Care. Currently, they are the Director of Business Development at ReviveMed.

Hamed Reyhanfard, Pharm.D, EMBA, has a diverse educational background. Hamed earned their Doctor of Pharmacy - PharmD from Shahid Beheshti University of Medical Sciences in 2011. In 2013, they obtained a Master's Degree in Biochemistry and Molecular Biology from Georgia State University. In 2015, they earned an Executive MBA from the MIT Sloan School of Management. Most recently, they completed a Master's degree in Marketing & Management from St. John's University in 2020.